Although fibrosis is one of the most prominent pathologic features of preeclamptic (PE) placentas, its mechanism remains largely unknown. Consistent with previous reports, we observed overexpression of collagen; actin, a2, smooth muscle, aorta; connective tissue growth factor; and fibronectin in PE placentas compared with control ones. To investigate the mechanism of fibrosis in PE placentas, placental fibroblasts were isolated from PE placentas or normal pregnancies at delivery. The expression of fibrosis-related factors in fibroblasts was evaluated by real-time RT-PCR, Western blotting, enzymelinked immunosorbent assay, and gene microarrays. An in vitro collagen gel contraction assay was also performed. Fibroblasts isolated from PE placentas showed higher expression levels of fibrosis-related factors compared with those from control ones. Global gene expression profiling of PE fibroblasts was contrasted with that of control ones and indicated an intimate association with transforming growth factor-b1 (TGFB1) signaling. Furthermore, the PE fibroblasts expressed abundant phosphorylated SMAD family member 2 and showed higher expression levels of target genes of TGFB1 signaling compared with the control ones. The PE fibroblasts also had a greater ability to contract compared with the control ones. Contractility also depended on TGFB1 signaling. Our results suggest that TGFB1 signaling is activated in the fibroblasts in PE placentas and that these active fibroblasts contribute to fibrosis. (Am J Pathol 2018, 188: 683e695; https://doi.
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The human placenta is a critical organ for growth and development of the fetus, consisting of the decidua basalis from maternal components and chorionic villi from the fetus. Chorionic villi include trophoblasts and villous stroma, which is originally derived from the extraembryonic mesoderm and consists of mesenchymal cells, reticulum cells, and fibroblasts. 1 Preeclampsia (PE) is a pregnancy-specific disease that is characterized by maternal hypertension and proteinuria; it affects 5% to 10% of all pregnancies. 2 The first stage of PE pathogenesis is thought to be associated with failure of trophoblast invasion into the maternal decidua, resulting in insufficient vascular remodeling. This physiological change induces oxidative stress, which finally causes systemic inflammation in the maternal body. 3 Histologic features of placentas in women with PE are characterized by chronic inflammation, vascular lesions, perivillous coagulation, and villous fibrosis. 4, 5 These features suggest that dysfunction of trophoblasts is just a part of the pathology of preeclampsia and that villous stroma is the main site affected by the disease. Among the changes occurring in the villous stroma of PE, fibrosis is one of the most prominent features. 4, 5 Fibrosis is a pathologic process, which takes place in response to tissue injury or inflammation, and is defined by overproduction of extracellular matrix (ECM) in the connective tissue. 6 Fibrosis plays a significant role in multiple organ failures, such as systemic sclerosis, idiopathic pulmonary fibrosis, liver cirrhosis, kidney fibrosis, and cardiac fibrosis. In normal physiological conditions, fibroblasts play pivotal roles in ECM maintenance and wound healing in the connective tissues. However, in a pathologic situation, uncontrolled activation of fibroblasts promotes excessive production of ECM and leads to fibrosis. 7 Activated fibroblasts might originate from tissue fibroblasts, endothelial cells, epithelial cells, pericytes, or bone marrowederived cells. 6, 8 The most well-known mechanism of fibrosis and fibroblast activation is the activity of transforming growth factor-b1 (TGFB1). 9, 10 Hypoxia and hypoxia-inducible factor 1a subunit are also known to contribute to fibrogenesis. 11 Hypoxia was reported to induce TGFB1 expression in fibroblasts. 12, 13 Lysophosphatidic acid, sphingosine-1phosphate, plasma coagulation cascade, and matrix metalloproteinases were also reported to promote fibrosis by activating fibroblasts. 14e17 Although the mechanism of fibrosis in the villous stroma of PE placentas is largely unknown, it has been suggested that ischemia and hypoxia are involved. 4, 5 In vitro culture of placental fibroblasts in hypoxic conditions stimulated the expression and production of ECM, fibronectins, and collagen type 4, which suggests the activation of fibroblasts. 18, 19 TGFB signaling has been also implicated to be involved in fibrosis of PE placentas. TGFB families are expressed in decidua cells and in the extracellular regions of villous stroma. 20, 21 Some studies reported that plasma levels of TGFB in cases of PE were significantly higher than those in controls. 22, 23 Treatment of placental fibroblasts with TGFB1 led to production of ECM, fibronectins, and collagen types 1 and 4. 19 As described earlier in this paragraph, there is only little known about fibrosis in PE placenta, and it is also unclear whether trophoblasts, fibroblasts, or both are involved in the fibrosis.
Herein, we focused on placental fibrosis as a feature of PE. We observed overproduction of ECM, including collagen (COL) and fibronectin (FN1), and overexpression of actin, a2, smooth muscle, aorta (ACTA2) and connective tissue growth factor (CTGF) in PE placentas compared with control ones. Fibroblasts isolated from PE placentas showed higher expression levels of these fibrosis-related factors compared with those from control ones. Furthermore, the PE fibroblasts expressed abundant phosphorylated SMAD family member 2 (SMAD2) and showed intimate association with TGFB1 signaling by microarray analysis. The PE fibroblasts also had a greater ability to contract compared with controls, measured by an in vitro contraction assay, which also depended on TGFB1 signaling. These data suggest that TGFB1 signaling is activated in the fibroblasts in PE placentas and contributes to fibrosis.
Materials and Methods

Participants and Samples
Case and control pregnant Japanese women who had a prenatal checkup and gave birth at Kyushu University Hospital between 2014 and 2016 were recruited to this study. Women with a multiple pregnancy, a fetus with malformations, or a fetus with chromosomal abnormalities were excluded. The participants were divided into two groups: a normal pregnancy (NP) group without any maternal or fetal complications, except for preterm birth (n Z 15), and a PE group (n Z 14) (Table 1) . PE was diagnosed on the basis of the defined criteria (blood pressure reading, twice, at least 6 hours apart, with a systolic blood pressure !140 mm Hg and/or a diastolic blood pressure !90 mm Hg), with proteinuria (!300 mg/day) during the second half of the pregnancy. All participants involved provided their written informed consent. This study was approved by the Ethical Committee of Kyushu University. Tissue blocks of a cross section of placenta located halfway between the cord insertion point and the lateral edge were dissected, and chorion and decidua were removed soon after deliveries and saved for histologic analysis and isolation of fibroblasts.
Immunohistochemistry and Image Analysis
Placenta tissue blocks were fixed with formalin and embedded in paraffin wax. Sections (4 mm thick) were subjected to standard Masson's trichrome staining to visualize COL deposition. For immunohistochemistry, sections were deparaffinized, rehydrated, and heated in Histofine (pH 9; Nichirei, Tokyo, Japan) to activate antigen. After endogenous peroxidase activity had been blocked by 3% hydrogen peroxide, the sections were blocked with Protein Block Serum-Free Ready-To-Use (Agilent Technologies, Santa Clara, CA) and were incubated with a primary antibody at 4 C overnight. The EnVisionþ dual-link systemehorseradish peroxidase (Agilent Technologies) was used for the addition of a secondary antibody and color development. Hematoxylin was used for counterstaining nuclei. Rabbit primary antibodies used were against ACTA2 (1:300; ab5694), CTGF (1:400; ab6992), and FN1 (1:300; ab23750) (all from Abcam, Cambridge, UK). The images were captured using a microscope (BZ-8100; Keyence, Osaka, Japan). One hundred fields with 10Â amplification were captured, and areas with and without positive signals were calculated using a BZ analyzer and Hybrid Cell Count (Keyence). The ratios of signalpositive areas/total tissue areas were calculated.
Cell Culture
Placental fibroblasts were isolated, as reported. 12, 24 In brief, 5 to 10 g of villous tissue was minced and digested with 0.1% collagenase solution for 30 minutes at 37 C using a rotating mixer. Dispersed cells were filtered through a 160mm metal mesh and collected by centrifugation at 500 Â g for 5 minutes. Then, the precipitate was gently suspended by pipetting with 2 mL of Dulbecco's modified Eagle's medium (DMEM; Nacalai Tesque, Kyoto, Japan) with 10% fetal bovine serum (FBS; Merck KGaA, Darmstadt, Germany) and plated. The cells were maintained in DMEM containing 10% FBS, penicillin (100 U/mL), and streptomycin (100 mg/mL) at 37 C in a 5% CO 2 atmosphere. Placental fibroblasts at passages 2 to 8 were used for experiments. As used in our previous study, HTR-8/SVneo and TCL-1 trophoblast cells were obtained and maintained in RPMI 1640 medium supplemented with 10% FBS, penicillin, and streptomycin. 25 
Real-Time RT-PCR
Total RNA was purified from fibroblasts with RNeasy Mini Kits (Qiagen, Hilden, Germany). Isolated RNA was reverse transcribed into cDNA using ReverTra Ace-a (Toyobo, Osaka, Japan). Real-time RT-PCR was performed using SYBR Premix ExTaqII (Takara, Shiga, Japan). The sequences for primers are shown in Table 2 . Relative expression levels were normalized to hypoxanthine phosphoribosyltransferase 1 and calculated using the 2 ÀDDCt method. Realtime RT-PCR for FN1 and secreted protein acidic and cysteine rich was performed using TaqMan primers and probe (FN1, Hs01549973_m1; secreted protein acidic and cysteine rich, Hs00234160_m1; Thermo Fisher Scientific, Waltham, MA) and TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific). Gene expression levels were obtained using individual values normalized to 18S rRNA (Hs99999901_s1; Thermo Fisher Scientific).
Western Blotting
Placental fibroblasts were harvested and lysed with Cell Lysis Buffer (Merck KGaA) with Protease Inhibitor Mixture (Nacalai Tesque) and phosphatase inhibitors (Nacalai Tesque). A total of 40 mg protein was loaded per lane, separated by 10% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). After blocking with Blocking One or Blocking One-P solutions (Nacalai Tesque) in tris-buffered saline containing 0.1% Tween 20 for 30 minutes at 37 C, the membranes were incubated with rabbit primary antibodies against COL1 (1:5000; 600-401-103-0.5; Rockland, Inc., Gilbertsville, PA), fibroblast activation protein (FAP; 1:1000; ab28244; Abcam), phospho-SMAD2 (1:1000; number 3108; Cell 
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The American Journal of Pathologyajp.amjpathol.org Signaling Technology, Danvers, MA), SMAD2 (1:1000; number 5339; Cell Signaling Technology), and ACTA2 (1:3000; ab5694; Abcam) at 4 C overnight. For internal control, we also determined the expression of glyceraldehyde-3-phosphate dehydrogenase (1:2000; FL-335; Santa Cruz Biotechnology, Dallas, TX). After washing four times with tris-buffered saline containing 0.1% Tween 20, the membranes were incubated with a goat anti-rabbit horseradish peroxidaseeconjugated secondary antibody for 1 hour at 37 C, followed by treatment with Clarity western electrochemiluminescence substrate detection kits (Bio-Rad, Hercules, CA), and subjected to a ChemiDoc XRS Touch Imaging System (Bio-Rad).
Immunofluorescence of Cells in Culture
Fibroblasts were seeded into multichamber culture slides (Lab-Tek, Naperville, IL) at a density of 5 Â 10 4 cells per chamber. The cells were fixed in 4% paraformaldehyde and blocked in Protein Block Serum-Free Ready-To-Use for 10 minutes. The cells were incubated overnight at 4 C with primary antibodies: mouse antiepan-keratin (1:400; C11; Cell Signaling Technology) and rabbit anti-vimentin (1:500; ab45939; Abcam). The cells were incubated for 30 minutes at room temperature with suitable combinations of the following secondary antibodies: Alexa Fluor 488econjugated donkey anti-rabbit IgG (1:500; A21206; Invitrogen Life Sciences, Carlsbad, CA) or Alexa Fluor 594econjugated goat anti-mouse IgG (1:500; A11005; Invitrogen Life Sciences). They were then mounted in ProLong Gold antifade reagent with DAPI (P36935; Invitrogen Life Sciences). Images were acquired using a BZ-8100 microscope (Keyence).
TGFB1 Treatment of Placental Fibroblasts
For the study of TGFB1 stimulation, placental fibroblasts maintained in DMEM with 10% FBS were transferred to serum-free DMEM for 24 hours. Then, recombinant human TGFB1 (number 100-21; PeproTech, Rocky Hill, NJ) was added to the serum-free DMEM at a final concentration of 10 ng/mL, and the fibroblasts were cultured for another 24 hours before sample collection.
Knockdown of TGFBR1 Gene Expression in Placental Fibroblasts
A validated siRNA for transforming growth factor beta receptor 1 (TGFBR1) (103324; Thermo Fisher Scientific) was used to compare with negative control siRNA (AM4611; Thermo Fisher Scientific). Lipofectamine RNAiMAX was used to transfect the siRNAs to placental fibroblasts (Thermo Fisher Scientific). Forty-eight hours after transfection in DMEM with 10% FBS, the fibroblasts were used for collagen gel contraction assay or collected directly for mRNA and protein assays.
Enzyme-Linked Immunosorbent Assay
The supernatant of serum-free DMEM incubated with fibroblasts for 24 hours was used to determine the concentrations of secreted TGFB1 and FN1. In the case of TGFB1 stimulation, after 24 hours' incubation with serum-free DMEM, fibroblasts were treated with or without TGFB1 (10 ng/mL) for another 24 hours. The concentrations of TGFB1 and FN1 were analyzed by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN). Assays were performed following instructions provided by the manufacturer. The concentrations were determined in triplicate wells.
Collagen Gel Contraction Assay
Collagen lattices were prepared using type I collagen (Cellmatrix, type 1-A; Kurabo, Osaka, Japan) to a final concentration of 2.1 mg/mL with 20 mmol/L HEPES, 
Sequence information can be obtained at https://www.ncbi.nlm.nih.gov/nuccore. 5 mmol/L NaOH, and 1Â DMEM. Aliquots of 300 mL of this mix were polymerized for 30 minutes at 37 C in 24well plates. Placental fibroblasts suspended in 300 mL serum-free DMEM (1 Â 10 5 cells/mL) were loaded onto the collagen lattices. After 12 hours' incubation, TGFB1 (final concentration, 10 ng/mL) was added. One hour after the addition, the collagen gels were released mechanically from the underlying dishes, and the diameters of the gels were measured at 6, 12, and 24 hours later. The relative diameter of the gels was calculated using the following formula: 100 Â (gel diameter)/(well diameter).
Whole-Genome Expression Analysis by Microarrays
DNA microarray analysis was performed using SurePrint G3 Human Gene Expression Microarrays 8 Â 60 K version 2 (Agilent Technologies). In brief, total RNA from fibroblasts maintained in DMEM with 10% FBS was prepared with the RNeasy Mini Kit. Relative target intensity was calculated using Agilent Feature Extraction Software version 9.5.1.1 (Agilent Technologies). The data were deposited at the National Center for Biotechnology Information (https://www. ncbi.nlm.nih.gov/geo; accession number GSE99007). We generated a heat map using MeV software version 4.8.1 (Multiple Experiment Viewer; http://www.tm4.org) and a hierarchical clustering method to sort the genes. Gene Set Enrichment Analysis (http://www.broadinstitute.org/gsea/ index.jsp) of the expression data was used to assess enrichment of the up-regulated genes from GSE40839 26 and GSE63659. 27 
Statistical Analysis
All experiments were repeated at least three times, with similar results in each instance. Results were analyzed using the nonparametric U-test, t-test, paired t-test, or Wilcoxon signed-rank test. P < 0.05 was considered significant.
Results
Fibrosis and the Expression of FRFs Are Prominent in PE Placentas
To examine the involvement of fibrosis in PE pathogenesis, collagen fibers in placenta tissue sections from PE and NP cases were visualized by Masson's trichrome staining procedure. Positive staining was observed in villous stroma of placentas ( Figure 1, A and B) . The ratio of the positive staining area was significantly higher in the PE group than in the NP group (P Z 0.002) ( Figure 1C ). On the basis of this result, the expression of levels fibrosis-related factors (FRFs), such as ACTA2, CTGF, and FN1, were next examined in the placental tissues. ACTA2 is a marker for myofibroblasts and active fibroblasts. 28 CTGF plays a central role in fibrosis and 
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The American Journal of Pathologyajp.amjpathol.org up-regulates the expression of FN1 and collagen type 4. 29 FN1 is an ECM protein playing an important role in the development of fibrotic disease. 30 Immunohistochemistry showed that the expression of ACTA2 was localized around intravillous vessels and in villous stroma (Figure 1 , D and E), the expression of CTGF was localized in villous stroma (Figure 1, G and H) , and the expression of FN1 was scattered in fibrous villous stroma (Figure 1, J and K) . Ratios of the immunopositive area for ACTA2, CTGF, and FN1 were significantly higher in the PE group than in the NP group (P < 0.05) (Figure 1 , F, I, and L).
Characterization of Placental Fibroblasts Isolated from Term Placentas
The data in Figure 1 suggested that abnormal fibrosis is a significant feature of PE placentas. Excessive production of ECM, and consequent fibrosis, is known to be promoted by aberrant activation of fibroblasts. 7 Therefore, fibroblasts were isolated from PE and NP placentas, and their characteristics were evaluated. To minimize the effects from culture conditions, the fibroblasts were analyzed within the first 8 cell culture passages. Fibroblasts originate from mesenchymal cells and should be positive for mesenchymal markers and negative for epithelial markers. At first, the fibroblasts isolated were confirmed for their homogeneity by immunocytochemistry. All of the fibroblasts were positive for a mesenchymal marker, vimentin, and negative for an epithelial marker, pan-keratins ( Figure 2A ). The mRNA expression of epithelial markers, cadherin 1, and vimentin in the fibroblasts was confirmed by real-time RT-PCR analysis in comparison with trophoblast cell lines, HTR-8/SVneo cells, and TCL-1 cells (Figure 2 , B and C). There were no remarkable differences in morphology or in the expression levels of mesenchymal/epithelial markers in between the fibroblasts from PE and those from NP cases ( Figure 2 ).
Expression Levels of FRFs Are Higher in the Fibroblasts from PE Placentas
Next, the expression levels of FRFs were compared between the fibroblasts from NP and PE placentas. The comparative mRNA levels of COL1A1, ACTA2, CTGF, and FN1 were higher in the fibroblasts from PE than in those from NP placentas (P < 0.05) (Figure 3 , AeD). The fibroblasts from PE placentas all expressed high protein levels of COL1A1, ACTA2, and FAP ( Figure 3E ). FAP is a transmembrane serine protease, possessing type 1 collagenespecific collagenase activity, and it is recognized as another marker of activated fibroblasts. 31 The protein secretion level of FN1 in the culture medium was assessed by enzyme-linked immunosorbent assay. The fibroblasts from PE placentas secreted larger amounts of FN1 than those from NP cases (P Z 0.002) ( Figure 3F ). These data indicated that the fibroblasts isolated from PE placentas were in a more activated state than those from NP placentas, even after several passages.
Expression of FRFs in the Placental Fibroblasts Does Not Depend on Placental Region of Sampling or Passage Numbers
It was previously reported that variations in the morphology and gene expression of different placental regions were dependent on the oxygen or nutrient gradient from the center to the lateral edge. 32 The regional differences of gene expression levels among PE fibroblasts from sites adjacent to the cord insertion site, halfway between the cord insertion point and the lateral edge and beside the lateral edge, were evaluated. However, no region-specific expression of FRFs was observed in fibroblasts (Supplemental Figure S1 , AeD). The passage numberedependency of gene expression was also examined in NP and PE fibroblasts. Three lines from NP and PE fibroblasts were cultured from passage 3 (passage 4 for some lines) to 8, and samples were collected at each passage. However, no remarkable difference in FRF expression was observed among the fibroblasts at each cell passage (Supplemental Figure S1 , EeI).
Genome-Wide Profiling of Gene ExpressioneAssociated PE Fibroblasts with Fibrosis and TGFB1 Signaling
To investigate the differential expression patterns of mRNAs in the fibroblasts between NP and PE placentas, a genome-wide RNA microarray analysis was performed. Hierarchical clustering of all genes formed depending on the gene expression patterns of PE and NP samples distinguished these two groups. The Tree View showed that each group appeared to have a specific gene profile ( Figure 4A ). Gene expression profiling in placental fibroblasts showed that 626 genes were differently expressed between PE and NP samples with LIMMA (twofold or greater; P 0.05). Up-regulated (n Z 358) and down-regulated (n Z 268) genes showed significant differences between the PE and NP fibroblasts.
Gene Set Enrichment Analysis showed remarkably positive correlations in the changes in gene expression profiles of fibroblasts from PE versus NP placentas and of those from idiopathic pulmonary fibrosis versus normal lung tissues ( Figure 4B ). 26 Gene Set Enrichment Analysis also showed remarkably positive correlation in changes in gene expression profiles of fibroblasts from PE versus NP placentas and of those from lung fibroblasts stimulated with TGFB1 versus nontreated controls ( Figure 4C ). 27 
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Ten genes with remarkable expression changes were selected to validate their altered expression in PE samples by real-time RT-PCR (Figure 4 , DeM). Among these genes, the expressions of IL15 and PGF are known to be associated with PE. 33, 34 FGF1, IGFBP3, and ADAM15 are associated with pulmonary or cardiac fibrosis. 35e37 COL8A1, IGFBP3, SPARC, FBN2, MMP9, and ITGA2 were reported to be affected by or to affect TGFBeSMAD signaling. 36,38e42 These data suggested that fibrosis and activated TGFB signaling are the characteristic features of PE fibroblasts.
Involvement of TGFB1 Signaling in Activated Fibroblasts from PE Placentas
Supported by the results in Figure 4 , it was further examined whether TGFB1 signaling was activated in PE fibroblasts. Phosphorylated SMAD2 (p-SMAD2) was first examined in serum-free conditions, as used for mRNA analysis; however, no detectable levels were observed in the fibroblasts. Therefore, 10% FBS conditions were used for the protein analysis shown in Figure 3E , which shows more than a detectable level of p-SMAD2 in most of the fibroblast samples from PE placentas. This result suggested that TGF-beSMAD signaling was activated in the PE fibroblasts. To explore the mechanism of aberrant activation of TGFB signaling in the PE fibroblasts, serum-free cell culture supernatants from the NP and PE fibroblasts were examined for their TGFB1 levels. Larger amounts of TGFB1 were secreted from the PE fibroblasts than from the NP fibroblasts ( Figure 3G) .
To explore the responsiveness of the fibroblasts to TGF-b1, both the PE and NP fibroblasts were treated with 10 ng/ mL of TGFB1 for 24 hours. Increased levels of COL1A1, ACTA2, CTGF, FN1, and FAP were observed in both types of fibroblasts in response to TGFB1 treatment (P < 0.05) (Figure 3 , AeD, and Figure 5A ). FN1 secretion was induced by TGFB1 treatment in NP fibroblasts (P Z 0.009) ( Figure 5B ). As expected, these responses were accompanied by up-regulation of p-SMAD2 ( Figure 5A ). These data suggest that both the NP and PE fibroblasts respond to TGF1 and that the aberrant activation of TGFB1eSMAD pathways was a characteristic of the PE fibroblasts.
Knockdown of TGFBR1 was also used to demonstrate the involvement of TGFB1eSMAD signaling in activated fibroblasts from PE cases. Successful knockdown of TGFBR1 in PE fibroblasts was verified by real-time RT-PCR ( Figure 5C ). As expected, knockdown of TGFBR1 resulted in a decrease in the p-SMAD2 level ( Figure 5D ). Furthermore, knockdown of TGFBR1 reduced the protein levels of COL1 and FAP and the mRNA levels of COL1A1, CTGF, and FN1 ( Figure 5, DeJ) . These data also suggested that the aberrant activation of TGFB1eSMAD pathway in PE fibroblasts was involved in the fibrogenesis of PE.
Fibroblasts from PE Cases Have a Greater Ability to Contract in Vitro
To assess the force-mediated matrix remodeling of placental fibroblasts in vitro, fibroblasts from NP and PE cases were loaded onto collagen lattices. The relative diameters of the collagen lattices were monitored at the defined time points. The fibroblasts from PE cases showed a greater ability to contract than those from NP cases ( Figure 6A ). The impact of TGFB1 on collagen contraction was also examined. As expected, addition of TGFB1 to the fibroblasts from NP cases enhanced collagen contraction ( Figure 6B ). By contrast, knockdown of TGFBR1 in the PE fibroblasts suppressed this contraction ( Figure 6C ). These data also Figure 5 Effects of treatment with TGFB1 or knockdown of TGFBR1 gene expression in placental fibroblasts. A: Protein levels of collagen 1 (COL1), fibroblast activation protein (FAP), phosphorylated SMAD2 (p-SMAD2), and total SMAD2 in fibroblasts from cases normal pregnancy (NP)-3 and preeclampsia (PE)-6 treated with or without 10 ng/mL TGFB1 for 24 hours were evaluated by Western blotting. B: Fibronectin (FN1) secretion into serum-free Dulbecco's modified Eagle's medium by fibroblasts treated with or without TGFB1 was evaluated by enzymelinked immunosorbent assay. C: Fibroblasts from cases PE-4, PE-5, and PE-6 were transfected with siRNA to knockdown TGFBR1 (siTGF-bR1). The mRNA levels of TGFBR1 in each fibroblast type were compared with control siRNA (siCtrl) by real-time RT-PCR. D: Protein levels of COL1, FAP, p-SMAD2, and total SMAD2 in fibroblasts from cases PE-3, PE-5, and PE-6 transfected with siCtrl and siTGFBR1 were evaluated. EeJ: mRNA levels of COL1A1 (E and H), connective tissue growth factor (F and I), and FN1 (G and J) in fibroblasts from cases PE-4 (EeG) and PE-5 (HeJ) transfected with siCtrl and siTGFBR1 were evaluated. *P < 0.05, **P < 0.01, and ***P < 0.001. GAPDH, glyceraldehyde-3phosphate dehydrogenase.
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Discussion
At the placental site of PE, deficiency of trophoblast invasion into the maternal decidua is considered to be the first stage of the two-stage theory. In the second stage, histologic features characterized by villous fibrosis become apparent. 4, 5 Although there is little known about the mechanism of placental fibrosis, TGFB1 is considered a trigger. 12, 19 TGFB1 is also implicated to regulate trophoblast differentiation and invasion, which determine the first stage of preeclampsia. 43, 44 Little is known about fibrosis in PE placentas, and it is also unclear whether trophoblasts, fibroblasts, or both are responsible for this pathologic change.
In the present study, placental fibrosis was studied as a feature of PE and the fibroblasts from PE placentas were characterized. Histology showed that the PE placentas overproduced collagen fibers and overexpressed ACTA2, CTGF, and FN1 (Figure 1) . These FRFs, such as COL1A1, ACTA2, CTGF, and FN1, have been suggested to be involved in PE-related fibrosis in the placenta. 45e47 Among these factors, CTGF was reported to be expressed in villous trophoblasts, consistent with our result ( Figure 1G ). 12 However, our data also showed that the stromal expression of CTGF was dominant in preeclampsia cases ( Figure 1H ). These results led us to focus on villous stromal mesenchyme, which is thought to have a central role in placental fibrosis. In addition, trophoblasts might directly or indirectly affect fibrosis in the villous stroma, and this remains to be studied in the future. Interestingly, primary culture of the fibroblasts isolated from PE placentas also showed higher expression levels of FRFs than in those from NP placentas (Figure 3) . These data suggest that the fibroblasts from PE placentas had been aberrantly activated and were kept activated, even after several passages in culture. The active state of PE fibroblasts was also demonstrated from a functional aspect ( Figure 6A ).
Samples collected from the placental disk, halfway between the cord insertion point and the lateral edge, were used for histologic analysis and the isolation of fibroblasts. At present, there are no standards for placental sampling to satisfy all researchers. Regarding the placental disk, variations in morphology and gene expression in different placental regions were reported to be dependent on the oxygen or nutrient gradient from the center to the lateral edge. 32 Although there have been several attempts to optimize placental sampling by multiple site sampling or randomization of sampling sites, site-directed sampling to exclude the interregional differences has been broadly accepted. 32,48e50 Experiments were conducted to evaluate the regional differences of gene expression among PE fibroblasts from sites adjacent to the cord insertion site, halfway between the cord insertion point and the lateral edge, and beside the lateral edge. However, no regionspecific expression of FRFs was observed in fibroblasts (Supplemental Figure S1 , AeD).
For exploring useful fibrosis-specific markers involved in PE-related fibrosis, a genome-wide gene expression analysis was applied by microarray. Gene expression profiling of the PE fibroblasts indicated strong associations with those seen in cases of idiopathic pulmonary fibrosis and TGFB1 stimulation (Figure 4 , B and C). Among the differentially Figure 6 Collagen gel contraction by placental fibroblasts. A: Fibroblasts from three normal pregnancy (NP; NP-2, NP-7, and NP-8) and three preeclampsia (PE; PE-4, PE-5, and PE-6) cases were evaluated for their in vitro contraction ability. B: Fibroblasts from four NP cases (NP-2, NP-3, NP-7, and NP-13) were treated with or without 10 ng/mL TGFB1 to evaluate their contraction in vitro. C: Fibroblasts from three PE cases (PE-4, PE-5, and PE-6) were transfected with control siRNA (siCtrl) or siRNA to knockdown TGFBR1 (siTGFBR1), and their contraction was evaluated in vitro. *P < 0.05, **P < 0.01, and ***P < 0.001. expressed genes, 10 were selected to validate their expression levels (Figure 4 , DeM). Among these, the expressions of IL15 and PGF are known to be associated with PE. Previous studies reported the expression of IL15 and PGF in the placental mesenchyme, 51, 52 but the association of IL15 and PGF in fibroblasts with preeclampsia remains unclear. 33, 34 In addition to FGF1, IGFBP3, and ADAM15, known to be associated with tissue fibrosis, 35e37 COL8A1 and SPARC, which are reported to be targets of TGFB1 signaling, were involved. 36, 38, 42 These data suggest that fibrosis and activated TGFB1 signaling are critical characteristics of PE fibroblasts.
Factors other than PE might affect gene expression in the placenta. Whole-genome analysis reported that gene expression of the placentas correlated with sex, delivery mode, and birth weight. 48 IL15 production from placental tissue explants was reported to be higher in term placental tissues than firsttrimester tissues. Furthermore, an increase in IL15 production was observed in placentas with the presence of labor at term. 53 All of the data were analyzed to evaluate any correlation of gene expression with maternal age, delivery week, delivery mode, infant body weight, or infant sex. However, no significant differences correlated with these factors. One limitation of our study was the sample size, which was too small to analyze potential association with each of these factors.
To exclude the effects of serum in culture, p-SMAD2 levels were first examined in serum-free conditions, as used for mRNA analysis; however, no detectable levels were observed in the fibroblasts ( Figure 5A ). Therefore, 10% FBS was used for protein analysis in Figure 3E . With this limitationdalthough it was not remarkabledmost of the PE fibroblasts expressed abundant p-SMAD2 ( Figure 3E ). These data also strengthen our contention that aberrant activation of TGFBeSMAD pathways was involved in the activation of fibroblasts from PE placentas.
Although the basal expression levels of FRFs were higher in the PE fibroblasts, the expression levels were enhanced in both NP and PE fibroblasts after exogenous TGFB1 treatment (Figure 3 , AeD, and Figure 5A ). These data also indicated that the NP and PE fibroblasts have a similar responsiveness to TGFB1 treatment. Induced levels of COL1A1, ACTA2, CTGF, FN1, and FAP are also known to occur in other fibroblast types stimulated by TGF-b1. 54e56 Furthermore, the fibroblasts from PE placentas secreted a larger amount of TGFB1 into the culture medium than those from NP placentas ( Figure 3G ). These results suggest that the autoinduction of TGFB1eSMAD signaling might be involved in the activation of the PE fibroblasts, as has been reported in fibroblasts from other organs. 57, 58 Because a higher plasma level of TGFB1 has been reported in patients with PE, 22, 23 the increased plasma level of TGFB1 might also participate in the activation of their fibroblasts. Furthermore, whether villous trophoblasts express and secrete TGFBs is currently controversial; however, TGFBs secreted from trophoblasts might also be involved in the activation of fibroblasts. 20, 21, 59, 60 In conclusion, we isolated fibroblasts from NP and PE placentas and clarified their characteristics. A detailed gene expression analysis revealed that higher levels of fibrosisrelated genes were expressed in the PE fibroblasts and that TGFB1 signaling was activated aberrantly. These novel insights may help us to elucidate the mechanism of placental dysfunction in PE and to develop a molecular strategy to treat affected patients.
